Trial Profile
A phase IIa, placebo controlled, randomized, cross-over study to evaluate the effects of DM-99 on a meal tolerance test in subjects with type 2 diabetes mellitus.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jul 2015
Price :
$35
*
At a glance
- Drugs DM 199 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 31 Mar 2009 Topline results have been reported in a DiaMedica media release. Overall results were inconclusive but support continued development of the DM 99 programme.
- 23 Dec 2008 New trial record.